THE SINGLE BEST STRATEGY TO USE FOR BREAST CANCER

Qualified protein degradation is currently being explored as an alternative strategy in cancer, whereby the normal protein degradation technique is co-opted for therapeutic needs. Not long ago created novel molecules identified as proteolysis-concentrating on chimeras (PROTACs) are heterobifunctional molecules with two ligands joined by a linker.